Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencingKarl Kashofer, Armin Zebisch, Heinz Sill et al.|Leukemia & lymphoma/Leukemia and lymphoma|2017Cited by 58
Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesisVeronica Caraffini, Armin Zebisch, Olivia Geiger et al.|Haematologica|2019Cited by 18
Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltrationVeronica Caraffini, Armin Zebisch, Bianca Perfler et al.|Blood|2018Cited by 16
EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivityJohannes Lorenz Berg, Armin Zebisch, Bianca Perfler et al.|Leukemia|2021Cited by 8